Aluminum oxide
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Name
- Aluminum oxide
- Accession Number
- DB11342
- Description
Aluminum oxide has a chemical formula Al2O3. It is amphoteric in nature, and is used in various chemical, industrial and commercial applications. It is considered an indirect additive used in food contact substances by the FDA.
- Type
- Small Molecule
- Groups
- Approved
- Structure
Structure for Aluminum oxide (DB11342)
- Weight
- Average: 101.96
Monoisotopic: 101.9478209 - Chemical Formula
- Al2O3
- Synonyms
- Aluminium oxide
Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:Accelerate your drug discovery research with our fully connected ADMET dataset- Indication
- Not Available
- Associated Conditions
- Contraindications & Blackbox Warnings
Contraindications & Blackbox WarningsWith our commercial data, access important information on dangerous risks, contraindications, and adverse effects.Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects- Pharmacodynamics
- Not Available
- Mechanism of action
- Not Available
- Absorption
- Not Available
- Volume of distribution
- Not Available
- Protein binding
- Not Available
- Metabolism
- Not Available
- Route of elimination
- Not Available
- Half-life
- Not Available
- Clearance
- Not Available
- Adverse Effects
Reduce medical errorsand improve treatment outcomes with our comprehensive & structured data on drug adverse effects.Reduce medical errors & improve treatment outcomes with our adverse effects data- Toxicity
- Not Available
- Affected organisms
- Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareEltrombopag Aluminum oxide can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy. 
Improve patient outcomesBuild effective decision support tools with the industry’s most comprehensive drug-drug interaction checker.Learn more - Food Interactions
- Not Available
Products
Comprehensive & structured drug product infoFrom application numbers to product codes, connect different identifiers through our commercial datasets.Easily connect various identifiers back to our datasets- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Brasivol Fine Cream Topical Stiefel Laboratories, Inc. 1966-12-31 2000-01-07 Canada 
Brasivol Medium Cream Topical Stiefel Laboratories, Inc. 1966-12-31 2000-01-07 Canada Vfb Bio Peel Powder 6.5 mg/1g Topical General Bio Co., Ltd. 2014-12-09 2019-09-30 US 
- Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Vfb Bio Peel Aluminum oxide (6.5 mg/1g) Powder Topical General Bio Co., Ltd. 2014-12-09 2019-09-30 US
Categories
- ATC Codes
- D10AX04 — Aluminium oxide
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of inorganic compounds known as post-transition metal salts. These are inorganic halogenic compounds in which the heaviest metal atom is a post-transition metal.
- Kingdom
- Inorganic compounds
- Super Class
- Mixed metal/non-metal compounds
- Class
- Post-transition metal salts
- Sub Class
- Not Available
- Direct Parent
- Post-transition metal salts
- Alternative Parents
- Miscellaneous mixed metal/non-metals / Inorganic salts
- Substituents
- Inorganic post-transition metal salt / Inorganic salt / Miscellaneous mixed metal/non-metal
- Molecular Framework
- Not Available
- External Descriptors
- Not Available
Chemical Identifiers
- UNII
- LMI26O6933
- CAS number
- 1344-28-1
- InChI Key
- PNEYBMLMFCGWSK-UHFFFAOYSA-N
- InChI
- InChI=1S/2Al.3O/q2*+3;3*-2
- IUPAC Name
- dialuminium(3+) ion trioxidandiide
- SMILES
- [O--].[O--].[O--].[Al+3].[Al+3]
References
- General References
- Not Available
- External Links
- PubChem Compound
- 9989226
- PubChem Substance
- 347827970
- ChemSpider
- 8164808
- 615
- ChEMBL
- CHEMBL3707210
- Wikipedia
- Aluminium_oxide
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Cream Topical Solution Intravenous 0 GBq Powder Topical 6.5 mg/1g - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP -0.65 ChemAxon pKa (Strongest Acidic) 15.7 ChemAxon pKa (Strongest Basic) -1.8 ChemAxon Physiological Charge 0 ChemAxon Hydrogen Acceptor Count 1 ChemAxon Hydrogen Donor Count 0 ChemAxon Polar Surface Area 0 Å2 ChemAxon Rotatable Bond Count 0 ChemAxon Refractivity 13.11 m3·mol-1 ChemAxon Polarizability 0.95 Å3 ChemAxon Number of Rings 0 ChemAxon Bioavailability 1 ChemAxon Rule of Five Yes ChemAxon Ghose Filter No ChemAxon Veber's Rule Yes ChemAxon MDDR-like Rule No ChemAxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Drug created on December 03, 2015 16:52 / Updated on June 12, 2020 16:53